These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 31863502)

  • 1. Short-chain fatty acids oppositely altered expressions and functions of intestinal cytochrome P4503A and P-glycoprotein and affected pharmacokinetics of verapamil following oral administration to rats.
    Zhang J; Xie Q; Kong W; Wang Z; Wang S; Zhao K; Chen Y; Liu X; Liu L
    J Pharm Pharmacol; 2020 Mar; 72(3):448-460. PubMed ID: 31863502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of Atorvastatin Pharmacokinetics in High-Fat Diet and Low-Dose Streptozotocin-Induced Diabetic Rats Using a Semiphysiologically Based Pharmacokinetic Model Involving Both Enzymes and Transporters.
    Wang Z; Yang H; Xu J; Zhao K; Chen Y; Liang L; Li P; Chen N; Geng D; Zhang X; Liu X; Liu L
    Drug Metab Dispos; 2019 Oct; 47(10):1066-1079. PubMed ID: 31399507
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dextran sulfate sodium-induced colitis and ginseng intervention altered oral pharmacokinetics of cyclosporine A in rats.
    Yang Y; Hu N; Gao XJ; Li T; Yan ZX; Wang PP; Wei B; Li S; Zhang ZJ; Li SL; Yan R
    J Ethnopharmacol; 2021 Jan; 265():113251. PubMed ID: 32810615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of simvastatin on the pharmacokinetics of verapamil and its main metabolite, norverapamil, in rats.
    Choi DH; Li C; Choi JS
    Eur J Drug Metab Pharmacokinet; 2009; 34(3-4):163-8. PubMed ID: 20166433
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneously predict pharmacokinetic interaction of rifampicin with oral versus intravenous substrates of cytochrome P450 3A/P‑glycoprotein to healthy human using a semi-physiologically based pharmacokinetic model involving both enzyme and transporter turnover.
    Qian CQ; Zhao KJ; Chen Y; Liu L; Liu XD
    Eur J Pharm Sci; 2019 Jun; 134():194-204. PubMed ID: 31047967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A semi-physiologically-based pharmacokinetic model characterizing mechanism-based auto-inhibition to predict stereoselective pharmacokinetics of verapamil and its metabolite norverapamil in human.
    Wang J; Xia S; Xue W; Wang D; Sai Y; Liu L; Liu X
    Eur J Pharm Sci; 2013 Nov; 50(3-4):290-302. PubMed ID: 23916407
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-chain fatty acids exert opposite effects on the expression and function of p-glycoprotein and breast cancer resistance protein in rat intestine.
    Xie QS; Zhang JX; Liu M; Liu PH; Wang ZJ; Zhu L; Jiang L; Jin MM; Liu XN; Liu L; Liu XD
    Acta Pharmacol Sin; 2021 Mar; 42(3):470-481. PubMed ID: 32555444
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible roles of intestinal P-glycoprotein and cytochrome P450 3A on the limited oral absorption of irinotecan.
    Yamasaki K; Hidaka M; Kawano Y; Furuya Y; Ono H; Arimori K
    J Pharm Pharmacol; 2021 Mar; 73(2):178-184. PubMed ID: 33793796
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Role of P-glycoprotein (P-gp)-Mediated Efflux in the Intestinal Absorption of Common Substrates with Elacridar, a P-gp Inhibitor, in Rats.
    Suzuki K; Taniyama K; Aoyama T; Watanabe Y
    Eur J Drug Metab Pharmacokinet; 2020 Jun; 45(3):385-392. PubMed ID: 32078103
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic interaction between oral lovastatin and verapamil in healthy subjects: role of P-glycoprotein inhibition by lovastatin.
    Choi DH; Chung JH; Choi JS
    Eur J Clin Pharmacol; 2010 Mar; 66(3):285-90. PubMed ID: 20012601
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In silico modeling for the nonlinear absorption kinetics of UK-343,664: a P-gp and CYP3A4 substrate.
    Abuasal BS; Bolger MB; Walker DK; Kaddoumi A
    Mol Pharm; 2012 Mar; 9(3):492-504. PubMed ID: 22264132
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of verapamil on the pharmacokinetics of rotundic acid in rats and its potential mechanism.
    Shang H; Wang Z; Ma H; Sun Y; Ci X; Gu Y; Liu C; Si D
    Pharm Biol; 2021 Dec; 59(1):200-208. PubMed ID: 33595422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of P-glycoprotein efflux on enterocyte residence time and enterocyte-based metabolism of verapamil.
    Johnson BM; Charman WN; Porter CJ
    J Pharm Pharmacol; 2001 Dec; 53(12):1611-9. PubMed ID: 11804391
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Decreased intestinal CYP3A and P-glycoprotein activities in rats with adjuvant arthritis.
    Uno S; Kawase A; Tsuji A; Tanino T; Iwaki M
    Drug Metab Pharmacokinet; 2007 Aug; 22(4):313-21. PubMed ID: 17827786
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of liver fibrosis on verapamil pharmacokinetics in rats.
    Chen M; Xu D; Hu XL; Wang H
    Clin Exp Pharmacol Physiol; 2008 Mar; 35(3):287-94. PubMed ID: 17973928
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of first-pass cytochrome P4503A (CYP3A) and P-glycoprotein activities using felodipine and hesperetin in combination in Wistar rats and everted rat gut sacs in vitro.
    Sridhar V; Surya Sandeep M; Ravindra Babu P; Naveen Babu K
    Phytother Res; 2014 May; 28(5):699-705. PubMed ID: 23881850
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of variations in the amounts of P-glycoprotein (ABCB1), BCRP (ABCG2) and CYP3A4 along the human small intestine on PBPK models for predicting intestinal first pass.
    Bruyère A; Declèves X; Bouzom F; Ball K; Marques C; Treton X; Pocard M; Valleur P; Bouhnik Y; Panis Y; Scherrmann JM; Mouly S
    Mol Pharm; 2010 Oct; 7(5):1596-607. PubMed ID: 20604570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drug interaction between oral atorvastatin and verapamil in healthy subjects: effects of atorvastatin on the pharmacokinetics of verapamil and norverapamil.
    Choi DH; Shin WG; Choi JS
    Eur J Clin Pharmacol; 2008 May; 64(5):445-9. PubMed ID: 18193210
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Huang-Lian-Jie-Du-Decoction on pharmacokinetics of verapamil in rats.
    Xie SS; Hu N; Jing XY; Liu XD; Xie L; Wang GJ; Liu CH
    J Pharm Pharmacol; 2010 Apr; 62(4):440-7. PubMed ID: 20604832
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Opposite effect of diabetes mellitus induced by streptozotocin on oral and intravenous pharmacokinetics of verapamil in rats.
    Hu N; Xie S; Liu L; Wang X; Pan X; Chen G; Zhang L; Liu H; Liu X; Liu X; Xie L; Wang G
    Drug Metab Dispos; 2011 Mar; 39(3):419-25. PubMed ID: 21135265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.